https://thelifesciencefeed.com/endocrinology/diabetes-mellitus-type-1/research/low-carb-diets-in-kids-with-type-1-diabetes-safe-but-not-standard The Life Science Feed en 2026-10-01T00:00:00Z Low-carb diets in kids with type 1 diabetes: safe, but not standard? https://thelifesciencefeed.com/endocrinology/diabetes-mellitus-type-2/research/oral-glp-1-is-it-time-to-rethink-insulin-glargine-for-t2d The Life Science Feed en 2026-10-01T00:00:00Z Oral GLP-1: Is it time to rethink insulin glargine for T2D? https://thelifesciencefeed.com/pediatrics/adhd/case/oral-pain-fever-in-teens-is-it-more-than-just-a-sore-throat The Life Science Feed en 2026-10-01T00:00:00Z Oral pain, fever in teens: Is it more than just a sore throat? https://thelifesciencefeed.com/genetics/genomic-medicine/research/ghkl-atpases-the-hidden-switch-driving-critical-cell-functions The Life Science Feed en 2026-10-01T00:00:00Z GHKL ATPases: The hidden switch driving critical cell functions? https://thelifesciencefeed.com/endocrinology/diabetes-mellitus-type-1/research/rotavirus-vaccine-and-t1d-is-an-11-rise-cause-for-alarm The Life Science Feed en 2026-10-01T00:00:00Z Rotavirus vaccine and T1D: Is an 11% rise cause for alarm? https://thelifesciencefeed.com/endocrinology/obesity/research/cbl-514-is-visceral-fat-reduction-the-real-story The Life Science Feed en 2026-10-01T00:00:00Z CBL-514: Is visceral fat reduction the real story? https://thelifesciencefeed.com/endocrinology/diabetes-mellitus-type-2/research/amylin-plus-tirzepatide-is-23-weight-loss-the-new-benchmark The Life Science Feed en 2026-10-01T00:00:00Z Amylin plus tirzepatide: Is 23% weight loss the new benchmark? https://thelifesciencefeed.com/neurology/neuropathic-pain/research/fibromyalgia-is-the-pain-real-if-the-tissue-damage-isnt The Life Science Feed en 2026-10-01T00:00:00Z Fibromyalgia: Is the pain real if the tissue damage isn't? https://thelifesciencefeed.com/endocrinology/diabetes-mellitus-type-1/research/type-1-diabetes-screening-why-one-protocol-worked-across-8-nations The Life Science Feed en 2026-10-01T00:00:00Z Type 1 diabetes screening: Why one protocol worked across 8 nations https://thelifesciencefeed.com/endocrinology/obesity/research/glp-1-weight-loss-is-muscle-loss-inevitable The Life Science Feed en 2026-10-01T00:00:00Z GLP-1 weight loss: Is muscle loss inevitable? https://thelifesciencefeed.com/endocrinology/diabetes-mellitus-type-2/research/early-type-2-diabetes-is-remission-the-new-normal-for-young-adults The Life Science Feed en 2026-10-01T00:00:00Z Early type 2 diabetes: Is remission the new normal for young adults? https://thelifesciencefeed.com/endocrinology/diabetes-mellitus-type-2/policy/diabetes-prevalence-is-your-diagnostic-method-missing-the-truth The Life Science Feed en 2026-10-01T00:00:00Z Diabetes prevalence: Is your diagnostic method missing the truth? https://thelifesciencefeed.com/ophthalmology/macular-degeneration/research/retinal-curl-the-visual-shortcut-for-heading-estimation The Life Science Feed en 2026-09-30T00:00:00Z Retinal curl: The visual shortcut for heading estimation https://thelifesciencefeed.com/endocrinology/diabetes-mellitus-type-2/research/glp-1s-for-young-t2d-are-we-underestimating-their-real-world-impact The Life Science Feed en 2026-09-30T00:00:00Z GLP-1s for young T2D: Are we underestimating their real-world impact? https://thelifesciencefeed.com/hepatology/hepatitis-b/research/chronic-hepatitis-b-is-pd-1-blockade-the-key-to-t-cell-revival The Life Science Feed en 2026-09-30T00:00:00Z Chronic hepatitis B: Is PD-1 blockade the key to T-cell revival? https://thelifesciencefeed.com/oncology/solid-tumors/research/salivary-gland-cancer-is-her2-low-the-new-her2-positive The Life Science Feed en 2026-09-30T00:00:00Z Salivary gland cancer: Is HER2-low the new HER2-positive? https://thelifesciencefeed.com/endocrinology/hypertension/news/why-stable-blood-pressure-isnt-always-stable-a-hidden-stroke-risk The Life Science Feed en 2026-09-29T00:00:00Z Why stable blood pressure isn't always stable: A hidden stroke risk? https://thelifesciencefeed.com/endocrinology/obesity/research/glp-1-intolerance-petrelintide-offers-a-new-path-to-weight-loss The Life Science Feed en 2026-09-29T00:00:00Z GLP-1 intolerance: Petrelintide offers a new path to weight loss? https://thelifesciencefeed.com/endocrinology/diabetes-mellitus-type-2/research/can-a-20-second-voice-recording-really-flag-type-2-diabetes The Life Science Feed en 2026-09-29T00:00:00Z Can a 20-second voice recording really flag type 2 diabetes? https://thelifesciencefeed.com/endocrinology/diabetes-mellitus-type-2/research/retatrutide-why-diabetes-patients-may-finally-match-weight-loss The Life Science Feed en 2026-09-29T00:00:00Z Retatrutide: Why diabetes patients may finally match weight loss https://thelifesciencefeed.com/endocrinology/obesity/policy/glp-1-drugs-work-better-for-women-yet-most-cant-get-them-why The Life Science Feed en 2026-09-29T00:00:00Z GLP-1 drugs work better for women, yet most can't get them. Why? https://thelifesciencefeed.com/obstetrics-and-gyn/pregnancy-complications/research/glp-1s-in-pregnancy-reassuring-data-one-unresolved-signal The Life Science Feed en 2026-09-29T00:00:00Z GLP-1s in pregnancy: Reassuring data, one unresolved signal https://thelifesciencefeed.com/endocrinology/diabetes-mellitus-type-2/insights/why-diabetes-risk-isnt-just-lifestyle-but-where-you-live The Life Science Feed en 2026-09-29T00:00:00Z Why diabetes risk isn't just lifestyle, but where you live https://thelifesciencefeed.com/cardiology/cardiac-biomarkers/guidelines/tactical-athletes-need-more-than-a-sports-physical The Life Science Feed en 2026-09-29T00:00:00Z Tactical athletes need more than a sports physical https://thelifesciencefeed.com/musculoskeletal/tendinopathy/research/rethinking-rehab-after-hip-and-knee-arthroplasty The Life Science Feed en 2026-09-29T00:00:00Z Rethinking rehab after hip and knee arthroplasty https://thelifesciencefeed.com/oncology/breast-neoplasms/policy/breast-cancer-home-injections-convenient-for-patients-complex-for-insurers The Life Science Feed en 2026-09-29T00:00:00Z Breast cancer home injections: Convenient for patients, complex for insurers https://thelifesciencefeed.com/pain-and-palliative-care/low-back-pain/insights/chronic-pain-why-your-organ-focused-treatment-may-fail-patients The Life Science Feed en 2026-09-29T00:00:00Z Chronic pain: Why your organ-focused treatment may fail patients https://thelifesciencefeed.com/endocrinology/obesity/news/obesity-rates-climb-what-does-this-mean-for-clinical-practice The Life Science Feed en 2026-09-29T00:00:00Z Obesity rates climb: What does this mean for clinical practice? https://thelifesciencefeed.com/neurology/alzheimer-disease/innovation/can-mice-learn-to-control-their-own-brains-a-new-neurofeedback-system The Life Science Feed en 2026-09-29T00:00:00Z Can mice learn to control their own brains? A new neurofeedback system https://thelifesciencefeed.com/neurology/alzheimer-disease/research/brexpiprazole-for-alzheimers-agitation-antidepressants-dont-change-efficacy The Life Science Feed en 2026-09-29T00:00:00Z Brexpiprazole for Alzheimer's agitation: Antidepressants don't change efficacy https://thelifesciencefeed.com/endocrinology/diabetes-mellitus-type-2/news/tirzepatide-why-modest-weight-regain-still-matters-for-control The Life Science Feed en 2026-09-29T00:00:00Z Tirzepatide: Why modest weight regain still matters for control? https://thelifesciencefeed.com/endocrinology/obesity/research/why-are-women-who-switch-birth-control-more-likely-to-start-semaglutide The Life Science Feed en 2026-09-29T00:00:00Z Why are women who switch birth control more likely to start semaglutide? https://thelifesciencefeed.com/dentistry/dental-caries/research/why-dont-humans-regenerate-teeth-like-cichlid-fish The Life Science Feed en 2026-09-29T00:00:00Z Why don't humans regenerate teeth like cichlid fish? https://thelifesciencefeed.com/endocrinology/diabetes-mellitus-type-2/research/semaglutide-and-pancreatic-cancer-is-the-risk-real The Life Science Feed en 2026-09-29T00:00:00Z Semaglutide and pancreatic cancer: Is the risk real?